Travere Therapeutics, Inc.

Connor, Clark & Lunn Investment Management Ltd. TVTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

623,390

Value ($000)

23,820

Weight

0.1%

2020 Q4 - 2025 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	23,820	0.1%	623,390	12/31/2025
2025 Q3	11/13/2025	20,504	0.1%	857,899	9/30/2025
2025 Q2	8/7/2025	10,146	0.0%	685,511	6/30/2025
2025 Q1	5/12/2025	8,874	0.0%	495,177	3/31/2025
2024 Q4	2/10/2025	7,434	0.0%	426,726	12/31/2024
2024 Q3	11/8/2024	7,350	0.0%	525,381	9/30/2024
2024 Q2	8/9/2024	3,883	0.0%	472,396	6/30/2024
2024 Q1	5/9/2024	3,212	0.0%	416,653	3/31/2024
2023 Q4	2/9/2024	2,587	0.0%	287,811	12/31/2023
2023 Q3	11/13/2023	2,600	0.0%	290,833	9/30/2023
2023 Q2	8/10/2023	4,468	0.0%	290,911	6/30/2023
2023 Q1	5/10/2023	6,230	0.0%	277,012	3/31/2023
2022 Q4	2/10/2023	5,148	0.0%	244,812	12/31/2022
2022 Q3	11/10/2022	6,082	0.0%	246,849	9/30/2022
2022 Q2	8/5/2022	5,756	0.0%	237,551	6/30/2022
2022 Q1	5/12/2022	6,076	0.0%	235,774	3/31/2022
2021 Q4	2/10/2022	7,151	0.0%	230,369	12/31/2021
2021 Q3	11/12/2021	4,080	0.0%	168,250	9/30/2021
2020 Q4	2/16/2021	338	0.0%	12,388	12/31/2020